Anti-SARS-CoV-2 Pharmacotherapies Among Nonhospitalized US Veterans, January 2022 to January 2023.

Lei Yan,Elani Streja,Yuli Li,Nallakkandi Rajeevan,Mazhgan Rowneki,Kristin Berry,Denise M Hynes,Francesca Cunningham,Grant D Huang,Mihaela Aslan,George N Ioannou,Kristina L Bajema

JAMA network open（2023）

引用 1|浏览12

暂无评分

摘要

This study found that prescription of outpatient COVID-19 pharmacotherapies in the VHA peaked in August 2022 and declined thereafter. There were large regional differences in patterns of nirmatrelvir-ritonavir and molnupiravir use.

查看译文

关键词

nonhospitalized us veterans,sars-cov

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要